Immunome Overview

Immunome Operating Income

Operating Income for IMNM.

Quarterly Operating Income

$-59331000.00

↑ 32.92% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-228808000.00

↑ 4.89% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin